The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Epidemiology of aquaporin‐4 autoimmunity and neuromyelitis optica spectrum
Open accessAbstract
Objective: Neuromyelitis optica (NMO) and its spectrum disorders (NMOSD) are inflammatory demyelinating diseases (IDDs) with a specific biomarker, aquaporin‐4–immunoglobulin G (AQP4‐IgG). Prior NMO/NMOSD epidemiological studies have been limited by lack of AQP4‐IgG seroprevalence assessment, absence of population‐based USA studies, and under‐representation of blacks. To overcome these limitations, we sought to compare NMO/NMOSD seroepidemiology across 2 ethnically divergent populations. Methods: We performed a population‐based comparative study of the incidence (2003–2011) and prevalence (on December 31, 2011) of NMO/NMOSD and AQP4‐IgG seroincidence and seroprevalence (sera collected in 80–84% of IDD cases) among patients with IDD diagnosis in Olmsted County, Minnesota (82% white [Caucasian]) and Martinique (90% black [Afro‐Caribbean]). AQP4‐IgG was measured by M1 isoform fluorescence‐activated cell‐sorting assays. Results: The age‐ and sex‐adjusted incidence (7.3 vs 0.7/1,000,000 person‐years [p < 0.01]) and prevalence (10 vs 3.9/100,000 [p = 0.01]) in Martinique exceeded that in Olmsted County. The AQP4‐IgG age‐ and sex‐adjusted seroincidence (6.5 vs 0.7/1,000,000 person‐years [p < 0.01]) and seroprevalence (7.9 vs 3.3/100,000 [p = 0.04]) were also higher in Martinique than Olmsted County. The ethnicity‐specific prevalence was similar in Martinique and Olmsted County: 11.5 and 13/100,000 in blacks, and 6.1 and 4.0/100,000 in whites, respectively. NMO/NMOSD represented a higher proportion of IDD cases in Martinique than Olmsted County (16% vs 1.4%; p < 0.01). The onset age (median = 35–37 years) and female:male distribution (5–9:1) were similar across both populations; 60% of prevalent cases were either blind in 1 eye, dependent on a gait aid, or both. Interpretation: This study reports the highest prevalence of NMO/NMOSD in any population (10/100,000 in Martinique), estimates it affects 16,000 to 17,000 in the USA (higher than previous predictions), and demonstrates it disproportionately affects blacks. Ann Neurol 2016;79:775–783
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22366 · Cited by 9,802
Self-citationInternational consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Wingerchuk, D. M., Banwell, B., Bennett, J. L., Cabre, P., Carroll, W., Chitnis, T., de Seze, J., Fujihara, K., Greenberg, B., Jacob, A., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001729 · Cited by 4,649 · cited 1×
“AQP4-IgG specificity allowed recognition of a broader clinical spectrum of NMO with similar natural history but not meeting these criteria (eg, recurrent AQP4-IgG–seropositive optic neuritis without transverse myelitis); these syndromes are known as NMO spectrum disorders (NMOSD).(5,6) Attacks are generally more sever…”
BackgroundSelf-citationNew Multiple Sclerosis Phenotypic Classification
Lublin, F. D. (2014) · European Neurology · doi:10.1159/000367614 · Cited by 4,259
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Lennon, V. A., Wingerchuk, D. M., Kryzer, T. J., Pittock, S. J., Lucchinetti, C. F., Fujihara, K., Nakashima, I., & Weinshenker, B. G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17551-x · Cited by 3,239
Self-citationRevised diagnostic criteria for neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F., & Weinshenker, B. G. (2006) · Neurology · doi:10.1212/01.wnl.0000216139.44259.74 · Cited by 2,574
Self-citationThe spectrum of neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Lucchinetti, C. F., Pittock, S. J., & Weinshenker, B. G. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70216-8 · Cited by 2,179
Self-citationThe clinical course of neuromyelitis optica (Devic’s syndrome)
Wingerchuk, D. M., Hogancamp, W. F., O’Brien, P. C., & Weinshenker, B. G. (1999) · Neurology · doi:10.1212/wnl.53.5.1107 · Cited by 1,822
Self-citationRuiter, A. M., Meilof, J. F., Somanje-Bolweg, R. R. J., van Gorsel, E., & Kalkers, N. F. (2017) · Case Reports in Neurology · doi:10.1159/000455942 · Cited by 1,762
Inequality in Quality: Addressing Socioeconomic, Racial, and Ethnic Disparities in Health Care
Fiscella, K., Franks, P., Gold, M. R., & Clancy, C. M. (2000) · JAMA · doi:10.1001/jama.283.19.2579 · Cited by 1,183
Proposed diagnostic criteria and nosology of acute transverse myelitis
Transverse Myelitis Consortium Working Group* (2002) · Neurology · doi:10.1212/wnl.59.4.499 · Cited by 808
The prevalence of multiple sclerosis in the world: an update
Rosati, G. (2001) · Neurological Sciences · doi:10.1007/s100720170011 · Cited by 656
St. Sauver, J. L., Grossardt, B. R., Yawn, B. P., Melton, L. J., & Rocca, W. A. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwq482 · Cited by 649
Acute disseminated encephalomyelitis
Tenembaum, S., Chitnis, T., Ness, J., & Hahn, J. S. (2007) · Neurology · doi:10.1212/01.wnl.0000259404.51352.7f · Cited by 631
Data Resource Profile: The Rochester Epidemiology Project (REP) medical records-linkage system
St Sauver, J. L., Grossardt, B. R., Yawn, B. P., Melton, L. J., Pankratz, J. J., Brue, S. M., & Rocca, W. A. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dys195 · Cited by 613
Proposed diagnostic criteria and nosology of acute transverse myelitis
Román, G. C. (2003) · Neurology · doi:10.1212/wnl.60.4.730 · Cited by 531
Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype
Kitley, J., Woodhall, M., Waters, P., Leite, M. I., Devenney, E., Craig, J., Palace, J., & Vincent, A. (2012) · Neurology · doi:10.1212/wnl.0b013e31826aac4e · Cited by 445
Demographic and clinical features of neuromyelitis optica: A review
Pandit, L., Asgari, N., Apiwattanakul, M., Palace, J., Paul, F., Leite, M., Kleiter, I., Chitnis, T., & the GJCF International Clinical Consortium & Biorepository for Neuromyelitis Optica (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515572406 · Cited by 341
Palace, J., Leite, M. I., Nairne, A., & Vincent, A. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.188 · Cited by 322
Epidemiology of Neuromyelitis Optica in the United States: A Multicenter Analysis
Mealy, M. A., Wingerchuk, D. M., Greenberg, B. M., & Levy, M. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.314 · Cited by 286
Self-citationA population-based study of neuromyelitis optica in Caucasians
Asgari, N., Lillevang, S. T., Skejoe, H. P. B., Falah, M., Stenager, E., & Kyvik, K. O. (2011) · Neurology · doi:10.1212/wnl.0b013e3182190f74 · Cited by 257
Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985–2000
Mayr, W. T., Pittock, S. J., McClelland, R. L., Jorgensen, N. W., Noseworthy, J. H., & Rodriguez, M. (2003) · Neurology · doi:10.1212/01.wnl.0000094316.90240.eb · Cited by 243
Self-citationDiscriminating long myelitis of neuromyelitis optica from sarcoidosis
Flanagan, E. P., Kaufmann, T. J., Krecke, K. N., Aksamit, A. J., Pittock, S. J., Keegan, B. M., Giannini, C., & Weinshenker, B. G. (2016) · Annals of Neurology · doi:10.1002/ana.24582 · Cited by 188
Self-citationAquaporin-4 antibody–negative neuromyelitis optica: Distinct assay sensitivity–dependent entity
Marignier, R., Bernard-Valnet, R., Giraudon, P., Collongues, N., Papeix, C., Zéphir, H., Cavillon, G., Rogemond, V., Casey, R., Frangoulis, B., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e318296e917 · Cited by 170
Role of return migration in the emergence of multiple sclerosis in the French West Indies
Cabre, P., Signaté, A., Olindo, S., Merle, H., Caparros-Lefebvre, D., Béra, O., & Smadja, D. (2005) · Brain · doi:10.1093/brain/awh624 · Cited by 159
Self-citationMS and neuromyelitis optica in Martinique (French West Indies)
Cabre, P., Heinzlef, O., Merle, H., Buisson, G. G., Bera, O., Bellance, R., Vernant, J. C., & Smadja, D. (2001) · Neurology · doi:10.1212/wnl.56.4.507 · Cited by 158
Self-citationPandit, L., & Kundapur, R. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514521503 · Cited by 135
Increased prevalence, incidence, and female predominance of multiple sclerosis in northern Japan
Houzen, H., Niino, M., Hirotani, M., Fukazawa, T., Kikuchi, S., Tanaka, K., & Sasaki, H. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.08.032 · Cited by 110
The prevalence of neuromyelitis optica in South East Wales
Cossburn, M., Tackley, G., Baker, K., Ingram, G., Burtonwood, M. T., Malik, G., Pickersgill, T. P., Naudé, J. T. W., & Robertson, N. P. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03529.x · Cited by 103
The epidemiology of neuromyelitis optica amongst adults in the Merseyside county of United Kingdom
Jacob, A., Panicker, J., Lythgoe, D. T., Elsone, L., Mutch, K., Wilson, M., Das, K., & Boggild, M. (2013) · Journal of Neurology · doi:10.1007/s00415-013-6926-y · Cited by 97
AQP4 autoantibody assay performance in clinical laboratory service
Fryer, J. P., Lennon, V. A., Pittock, S. J., Jenkins, S. M., Fallier‐Becker, P., Clardy, S. L., Horta, E. S., Jedynak, E. A., Lucchinetti, C. F., Shuster, E. A., et al. (2014) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000011 · Cited by 97
Self-citationNeuromyelitis Optica Spectrum Disorders
Flanagan, E. P., & Weinshenker, B. G. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0483-3 · Cited by 77
Self-citationPittock, S. J., Lennon, V. A., Bakshi, N., Shen, L., McKeon, A., Quach, H., Briggs, F. B. S., Bernstein, A. L., Schaefer, C. A., & Barcellos, L. F. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.1581 · Cited by 67
Self-citationIntractable Nausea and Vomiting From Autoantibodies Against a Brain Water Channel
Iorio, R., Lucchinetti, C. F., Lennon, V. A., Farrugia, G., Pasricha, P. J., Weinshenker, B. G., & Pittock, S. J. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.11.021 · Cited by 59
Self-citationAquaporin 4 IgG Serostatus and Outcome in Recurrent Longitudinally Extensive Transverse Myelitis
Jiao, Y., Fryer, J. P., Lennon, V. A., McKeon, A. B., Jenkins, S. M., Smith, C. Y., Quek, A. M. L., Weinshenker, B. G., Wingerchuk, D. M., Shuster, E. A., et al. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.5055 · Cited by 55
Self-citation
Cited by
Gilhus, N. E. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1602678 · Cited by 1,048
Flanagan, E. P., Hinson, S. R., Lennon, V. A., Fang, B., Aksamit, A. J., Morris, P. P., Basal, E., Honorat, J. A., Alfugham, N. B., Linnoila, J. J., et al. (2017) · Annals of Neurology · doi:10.1002/ana.24881 · Cited by 550
Self-citationJarius, S., Paul, F., Weinshenker, B. G., Levy, M., Kim, H. J., & Wildemann, B. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0214-9 · Cited by 478
Self-citationMechanisms of Autoantibody-Induced Pathology
Ludwig, R. J., Vanhoorelbeke, K., Leypoldt, F., Kaya, Z., Bieber, K., McLachlan, S. M., Komorowski, L., Luo, J., Cabral-Marques, O., Hammers, C. M., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00603 · Cited by 469
Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide
Hor, J. Y., Asgari, N., Nakashima, I., Broadley, S. A., Leite, M. I., Kissani, N., Jacob, A., Marignier, R., Weinshenker, B. G., Paul, F., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00501 · Cited by 413
Self-citation
Metadata
- Authors
- Flanagan, E. P., Cabre, P., Weinshenker, B. G., Sauver, J. S., Jacobson, D. J., Majed, M., Lennon, V. A., Lucchinetti, C. F., McKeon, A., Matiello, M., Kale, N., Wingerchuk, D. M., Mandrekar, J., Sagen, J. A., Fryer, J. P., Robinson, A. B., & Pittock, S. J.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2016-04-04
- Volume
- 79
- Issue
- 5
- Pages
- 775-783
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2278851035
- Cited by
- 338
- References
- 35
- FWCI
- 24.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.